TrialAntimicrobial agents and chemotherapy2005

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.

S Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.